{
    "headline": "Coronavirus Fda Approves New Round Covid 19 Vaccines",
    "summary": "The United States Food and Drug Administration approved a new round of vaccines against COVID-19.Key Quotes:According to a statement from the FDA, the new vaccines \u201cmore closely target currently circulating variants\" and \"provide better protection against serious consequences of COVID-19, including hospitalization and death.\" The FDA is \"confident in the safety and effectiveness of these updated vaccines and the agency\u2019s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks.\" The FDA also stated, \u201c\u200b\"Barring the emergence of a markedly more virulent variant, the FDA anticipates that the composition of COVID-19 vaccines may need to be updated annually, as is done for the seasonal influenza vaccine.\"Details:The new vaccines from Moderna and Pfizer-BioNTech have been approved for adults and children 6 months and older. These shots will be the first round of COVID-19 vaccines that are sold commercially by manufacturers and not purchased by the federal government. According to theWall Street Journal (Center bias), the Moderna vaccine will cost $130 per dose, but many individuals with health insurance will not have to pay out of pocket.How the Media Covered It:Outlets across the spectrum reported on the new vaccines in tandem with rising case numbers in the U.S.The Washington Examiner (Lean Right bias)included a quote from WHO COVID-19 Technical Lead Maria Van Kerkhove, who stated last week that data on the vaccine\u2019s effectiveness is \"quite limited so far.\"",
    "story": {
        "left": [
            "https://www.theguardian.com/us-news/2023/sep/11/new-covid-vaccine-booster-shot-fda-variants"
        ],
        "center": [
            "https://www.wsj.com/health/healthcare/fda-approves-newest-covid-19-boosters-c69f85e2"
        ],
        "right": [
            "https://www.washingtonexaminer.com/policy/healthcare/covid-19-boosters-approved-by-fda"
        ]
    }
}